This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's Mad Dash: How Healthy Is CVS?

NEW YORK (TheStreet) -- Shares of CVS Caremark (CVS - Get Report) are muted after the company released its first-quarter earnings. Although the company beat on revenue estimates, TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, was more concerned about the company's declining same-store sales, which fell 3.8%.

"That took my breath away," he said on CNBC's "Cramer's Mad Dash" segment Friday. 

Investors have to know why same-store sales decline so much, especially since Rite-Aid (RAD - Get Report), which many consider a "second-rate CVS," saw same-store sales climb 4.7%, he said. 

Rite-Aid and CVS have many similar locations, likely making some investors wonder if Rite-Aid is taking market share from CVS. 

However, don't write off CVS just yet. It's "a great company" and could be a buying opportunity, Cramer concluded. He just wants to know why same-store sales declined so meaningfully.


-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CVS $101.58 0.00%
RAD $8.25 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs